Plazomicin Nitroso Impurity 1
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. Plazomicin is a parenterally administered, broad spectrum aminoglycoside antibiotic typically used for moderate-to-severe urinary tract infections or pyelonephritis.Plazomicin Nitroso Impurity 1 is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
Plazomicin Nitroso Impurity 1 CAS NO:NA Chemically represented as (S)-4-amino-N-((1R,2S,3S,4R,5S)-5-amino-4-(((2S,3R)-3-amino-6-(((2-hydroxyethyl)amino)methyl)-3,4-dihydro-2H-pyran-2-yl)oxy)-2-(((2R,3R,4R,5R)-3,5-dihydroxy-5-methyl-4-(methyl(nitroso)amino)tetrahydro-2H-pyran-2-yl)oxy)-3-hydroxycyclohexyl)-2-hydroxybutanamide. Synchemia is the leading manufacturing and exporter of Plazomicin Nitroso Impurity 1. We supply Plazomicin Nitroso Impurity 1 with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N0141523 |
| CAS No | NA |
| Mol.F. | C16H16ClFN4O2 |
| Mol.Wt. | 350.8 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141524 |
| CAS No | 59467-62-8 |
| Mol.F. | C16H12ClFN4O |
| Mol.Wt. | 330.7 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141525 |
| CAS No | NA |
| Mol.F. | C16H12ClFN4O2 |
| Mol.Wt. | 346.7 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141526 |
| CAS No | NA |
| Mol.F. | C16H10ClFN4O4 |
| Mol.Wt. | 376.7 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141527 |
| CAS No | NA |
| Mol.F. | C18H20N2O2 |
| Mol.Wt. | 296.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141528 |
| CAS No | NA |
| Mol.F. | C8H8N8O2 |
| Mol.Wt. | 248.2 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141529 |
| CAS No | NA |
| Mol.F. | C14H17N7O2 |
| Mol.Wt. | 315.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141530 |
| CAS No | NA |
| Mol.F. | C12H17N3O2 |
| Mol.Wt. | 235.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141531 |
| CAS No | NA |
| Mol.F. | C12H17N3O2 |
| Mol.Wt. | 235.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141532 |
| CAS No | NA |
| Mol.F. | C10H11ClN2O2 |
| Mol.Wt. | 226.66 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141533 |
| CAS No | NA |
| Mol.F. | C13H19N3O2 |
| Mol.Wt. | 249.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141534 |
| CAS No | NA |
| Mol.F. | C12H17N3O2 |
| Mol.Wt. | 235.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141535 |
| CAS No | NA |
| Mol.F. | C30H37N3O3 |
| Mol.Wt. | 487.6 |
| INV STATUS | In Stock |
| CAT No | SRC-N0141536 |
| CAS No | NA |
| Mol.F. | C28H33N3O3 |
| Mol.Wt. | 459.6 |
| INV STATUS | In Stock |
| CAT No | SRC-N0141537 |
| CAS No | NA |
| Mol.F. | C30H37N3O3 |
| Mol.Wt. | 487.6 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141538 |
| CAS No | NA |
| Mol.F. | C26H22FIN6O5 |
| Mol.Wt. | 644.7 |
| INV STATUS | CUSTOM SYNTHESIS |